Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive neurodegenerative disease, and only modest disease-modifying strategies have been established to date. Numerous clinical trials have been conducted in the past years, but have been severely hampered by the wide-ranging heterogeneity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreger, Marie, Steinbach, Robert, Otto, Markus, Turner, Martin R, Grosskreutz, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neuromuscular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921583/
https://www.ncbi.nlm.nih.gov/pubmed/35105727
http://dx.doi.org/10.1136/jnnp-2021-327503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921583/
https://www.ncbi.nlm.nih.gov/pubmed/35105727
http://dx.doi.org/10.1136/jnnp-2021-327503

Ejemplares similares